Technical Analysis for PRTK - Paratek Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade D 6.72 3.23% 0.21
PRTK closed up 3.23 percent on Friday, January 18, 2019, on 76 percent of normal volume. The stock rose above its 50 day moving average, improving its intermediate-term outlook by crossing above that important trendline. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical PRTK trend table...

Date Alert Name Type % Chg
Jan 18 Crossed Above 50 DMA Bullish 0.00%
Jan 18 Expansion Pivot Buy Setup Bullish Swing Setup 0.00%
Jan 18 Pocket Pivot Bullish Swing Setup 0.00%
Jan 18 Weak + Overbought Other 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 17 Fell Below 50 DMA Bearish 3.23%
Jan 17 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 3.23%
Jan 17 MACD Bullish Centerline Cross Bullish 3.23%
Jan 17 Weak + Overbought Other 3.23%

Older signals for PRTK ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Paratek Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of antibiotics to save lives and alleviate suffering. It offers, omadacycline, a tetracycline-derived, broad-spectrum antibiotic for use as a first-line monotherapy for acute bacterial skin and skin structure infections, community-acquired bacterial pneumonia, urinary tract infections, and other serious community-acquired bacterial infections. The company also provides WC 3035, a tetracycline-derived compound with dual narrow-spectrum antibacterial and potent anti-inflammatory activity for use in the treatment of acne and rosacea. In addition, it offers solutions for multiple sclerosis, SMS, and RA/IBD. Paratek Pharmaceuticals, Inc. was founded in 1996 and is headquartered in Boston, Massachusetts.
Is PRTK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 16.35
52 Week Low 4.5
Average Volume 462,407
200-Day Moving Average 9.39
50-Day Moving Average 6.5148
20-Day Moving Average 5.7595
10-Day Moving Average 6.297
Average True Range 0.3596
ADX 27.28
+DI 28.438
-DI 13.8912
Chandelier Exit (Long, 3 ATRs ) 5.7312
Chandelier Exit (Short, 3 ATRs ) 5.5788
Upper Bollinger Band 6.9672
Lower Bollinger Band 4.5518
Percent B (%b) 0.9
BandWidth 41.937668
MACD Line 0.0451
MACD Signal Line -0.1372
MACD Histogram 0.1823
Fundamentals Value
Market Cap 186.55 Million
Num Shares 27.8 Million
EPS -3.95
Price-to-Earnings (P/E) Ratio -1.70
Price-to-Sales 77.65
Price-to-Book 5.15
PEG Ratio -0.02
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 7.23
Resistance 3 (R3) 7.20 7.01 7.15
Resistance 2 (R2) 7.01 6.88 7.02 7.12
Resistance 1 (R1) 6.86 6.80 6.94 6.89 7.09
Pivot Point 6.67 6.67 6.70 6.68 6.67
Support 1 (S1) 6.52 6.54 6.60 6.55 6.35
Support 2 (S2) 6.33 6.46 6.34 6.32
Support 3 (S3) 6.18 6.33 6.30
Support 4 (S4) 6.21